Last updated on September 2020

Long Term Safety and Efficacy Study of SAR442168 in Participants With Relapsing Multiple Sclerosis

Brief description of study

Primary Objective:

To determine the long-term safety and tolerability of SAR442168 in RMS participants

Secondary Objective:

To evaluate efficacy of SAR442168 on disease activity, assessed by clinical and imaging methods

Detailed Study Description

Approximately 62 months including the 8 weeks post-treatment visit

Clinical Study Identifier: NCT03996291

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.